News

QuickChek – May 3, 2021

Markets
0 min read



Golden Predator Mining Corp. Announces Termination of Arrangement Agreement with Viva Gold Corp

Golden Predator Mining and Viva Gold Corp have mutually agreed to terminate the arrangement agreement dated March 2, 2021 for the proposed acquisition of all of the issued and outstanding shares of Viva Gold by Golden Predator

Research, News & Market Data on Golden Predator Mining

Watch recent presentation from Golden Predator Mining



Total Cray Valley and Gevo to further Scale Up Development of Renewable Isoamylene from Fusel Oil

Gevo and Total Cray Valley announced the successful completion of phase 1 of their Joint Development Agreement to upgrade fusel oils into renewable isoamylene

Research, News & Market Data on Gevo

Watch recent Gevo presentation from NobleCon17



Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2. Up 17% in early trading.

Ocugen, Inc. announced that in a new study, scientists at Indian Council of Medical Research (ICMR)-National Institute of Virology have found that COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2

Research, News & Market Data on Ocugen

Watch recent presentation from NobleCon17



Dyadic to Present at Upcoming Events

Dyadic announced that the Company will participate in several upcoming events

Research, News & Market Data on Dyadic



Comtech Awarded $6.2 Million of Additional Funding to Support the U.S. Army’s Blue Force Tracking System

Comtech Telecommunications announced that during its third quarter of fiscal 2021, its Government Solutions segment was awarded $6.2 million of additional funding for Option Period Four of contract GS03Q17DSC0002

Research, News & Market Data on Comtech

Watch recent presentation from NobleCon17



Avivagen Announces Recurring Order for OxC-betaTM Livestock

Avivagen announced that Avivagen’s consultant in Mexico has secured their largest purchase amount and longest duration purchase to date

Research, News & Market Data on Avivagen

Watch recent presentation from NobleCon17



TAAL Files 2020 Fiscal Year-End Financial Results And Provides Operational Guidance For 2021

TAAL announced its financial results and Management Discussion and Analysis for the fiscal year ended December 31, 2020

Research, News & Market Data on TAAL Distributed Information Technologies

Watch recent presentation from NobleCon17



OpRegen® Clinical Data Continues To Demonstrate Improvements In Patients With Dry Amd With Geographic Atrophy

Lineage Cell Therapeutics announced that updated interim results from its ongoing, 24-patient Phase 1/2a clinical study of its lead product candidate, OpRegen, were reported at the 2021 Association for Research in Vision and Ophthalmology Annual Meeting

Research, News & Market Data on Lineage Cell Therapeutics

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

Share

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.